| Application no. and date | 13752753.7 (espacenet) (Federated) (European Patent Register), 20130808 | | Patent/reg. no. and date | DK/EP 2882441, 20200429 | | Publication date | 20150617 | | Priority no. and date | US 201261681491 P, 20120809, US 201261722718 P, 20121105 | | EP pub. no. and date |
EP 2882441 20150617 | | Effective date | | | Applicant/owner | Celgene Corporation, 86 Morris Avenue
Summit, NJ 07901, US | | Applicant ref. no. | P72955DK01 | | Inventor | SCHAFER, Peter, H., 126 John E. Busch Avenue
Somerset, NJ 08873, US,
GANDHI, Anita, 37 Stirling Road
Bernardsville, NJ 07924, US,
CHOPRA, Rajesh, Flat 5, Ruvigny Mansions
Putney Embankment
London SW15 1LE, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/5355 (2006.01) , A61K 31/5377 (2006.01) , A61P 37/00 (2006.01) , A61P 37/06 (2006.01) | | Title | BEHANDLING AF IMMUNRELATEREDE OG INFLAMMATORISKE SYGDOMME | | Int. application no. | US2013054051 | | Int. publication no. | WO2014025958 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
